Prostate cancer

Editorial

I M Thompson. J Urol. 1997 Mar.

. 1997 Mar;157(3):919-20.

doi: 10.1016/s0022-5347(01)65083-3.

No abstract available

Comment on

Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial.
Smith JA Jr, Scardino PT, Resnick MI, Hernandez AD, Rose SC, Egger MJ. Smith JA Jr, et al. J Urol. 1997 Mar;157(3):902-6. J Urol. 1997. PMID: 9072596 Clinical Trial.
Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of carcinoma of the prostate: ethnic variations.
Presti JC Jr, Hovey R, Bhargava V, Carroll PR, Shinohara K. Presti JC Jr, et al. J Urol. 1997 Mar;157(3):907-11; discussion 911-2. J Urol. 1997. PMID: 9072597 Clinical Trial.
Detection of prostate cancer relapse with prostate specific antigen monitoring at levels of 0.001 to 0.1 microG./L.
Yu H, Diamandis EP, Wong PY, Nam R, Trachtenberg J. Yu H, et al. J Urol. 1997 Mar;157(3):913-8. J Urol. 1997. PMID: 9072598 Clinical Trial.